Catalyst Health (CHSI) Boosts FY11 EPS, Sales Outlook

Catalyst Health (Nasdaq: CHSI) raises its FY11 adj-EPS guidance from $2.20-$2.39 to $2.30-$2.40, which compares to the Street estimate of $2.29. Sees sales of $5.1-$5.3 billion, versus the consensus of $5.2 billion. The company previously guided FY sales to $4.6-$4.8 billion.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
• Ocean Power Technologies revises fiscal 2026 results after audit